<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> occasionally results in <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>, it is difficult to differentiate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> from AA with small numbers of CD(55) (-)CD(59) (-) erythrocytes </plain></SENT>
<SENT sid="1" pm="."><plain>We quantified CD55 and CD59 molecules expressed on <z:mpath ids='MPATH_458'>normal</z:mpath> reticulocytes and mature erythrocytes of <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>), <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), and <z:mpath ids='MPATH_458'>normal</z:mpath> individuals in order to determine their usefulness for differentiation between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and AA </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 56 patients (AA 39 patients, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> 17 patients) and 10 healthy volunteers were enrolled </plain></SENT>
<SENT sid="3" pm="."><plain>Two-color flow cytometric analyses were conducted using <z:chebi fb="0" ids="52293">thiazole orange</z:chebi>, anti-CD55 and CD59 monoclonal antibodies to identify CD(55) (-)CD(59) (-) reticulocytes and mature erythrocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Mean fluorescence level of CD(55) (+) mature erythrocytes was lowest in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patients (13.2 x 10(3) MESF), and was significantly lower than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (16.7 x 10(3) MESF, p &lt;0.05), and highest in the AA subjects (22.8 x 10(3) MESF) </plain></SENT>
<SENT sid="5" pm="."><plain>Mean fluorescence level of CD(59) (+) mature erythrocytes was lowest in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> subjects (24.5 x 10(3) MESF), significantly less than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (39.0 x 10(3) MESF, p &lt;0.05), and highest in the AA subjects (49.2 x 10(3) MESF) </plain></SENT>
<SENT sid="6" pm="."><plain>Total reticulocyte counts correlated strongly with the CD(55) (-)CD(59) (-) reticulocytes </plain></SENT>
<SENT sid="7" pm="."><plain>Comparative quantitative analysis of CD55 and CD59 molecules expressed on <z:mpath ids='MPATH_458'>normal</z:mpath> erythrocytes may be useful in differentiating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> from AA patients with small numbers of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-phenotype erythrocytes, and the total reticulocyte count may prove useful as a marker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone size </plain></SENT>
</text></document>